A pilot randomized clinical trial of base-in prism spectacles for intermittent Exotropia,
Role: PI,
Status: Completed
Federal
A randomized clinical trial of overminus spectacle therapy for intermittent exotropia (IXT5),
Role: PI,
Jaeb Center for Health Research,
(05/2022 - 05/2023)
Status: Completed
Amblyopia treatment study (ATS20) binocular dig rush game treatment for amblyopia,
Role: PI,
Jaeb Center for Health Research,
(06/2020 - 06/2021)
Status: Completed
Amblyopia Treatment Study ATS20 Binocular Dig Rush Game Treatment for Amblyopia,
Role: Principal Investigator,
Jaeb Center for Health Research,
(09/2017 - 12/2023)
Status: Awarded
Intermittent Exotropia Study 5 (IXT5) A Randomized Clinical Trial of Overminus Spectable Therapy for Intermittent Exotropia,
Role: Principal Investigator,
Jaeb Center for Health Research,
(09/2017 - 12/2023)
Status: Awarded
For Profit Organization
A phase 2/3, randomized, double-masked, sham-controlled trial of QPI-1007 delivered by single or multi-dose intravitreal injection(s) to subjects with acute nonarteritic anterior ischemic optic neuropathy (NAION),
Role: Investigator,
Quark Pharmaceuticals,
(01/2019 - 01/2020)
Status: Completed
The efficacy and safety of Bimatoprost SR in patients with open-angle glaucoma or ocular hypertension,
Role: Investigator,
Allergan Inc.,
(01/2019 - 01/2020)
Status: Completed
Visual Outcomes in Patients Treated with Acetazolamide for Papilledema Secondary to Intracranial Mass Effect,
Role: PI,
LLU Dept. of Ophthalmology,
(01/2024)
Status: Approved
The incidence of dry eye syndrome in patients with pituitary tumors with and without transsphenoidal hypophysectomy,
Role: PI,
LLU Dept. of Ophthalmology,
(07/2019)
Status: Approved